Table: Kubota Pharmaceutical Holdings - group results (SEC)
May 10 (Reuters)-
Kubota Pharmaceutical Holdings Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
ended ended Yearto
Mar 31, 2016 Dec 31, 2017
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 0 mln 0 mln
Operating loss 1.03 loss 4.29
Pretax loss 983 mln loss 4.18
Net loss 983 mln loss 4.18
EPS loss 25.98 yen loss 110.00 yen
EPS Diluted loss 25.98 yen
Ann Div NIL NIL
-Q2 Div NIL NIL
-Q4 Div NIL NIL
NOTE - Kubota Pharmaceutical Holdings Co., Ltd..
(Figures are reported based on U.S. accounting rules set by the U.S. Securities
and Exchange Commission.)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Kubota Pharmaceutical Holdings
See all newsTable: Kubota Pharmaceutical Holdings 6-MTH group results (IFRS)
Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)
Brief: Kubota Vision Signs Supply & Licensing Agreement With Laboratoires Kôl
Table: Kubota Pharmaceutical Holdings -2025 parent results
Table: Kubota Pharmaceutical Holdings -2025 group results (IFRS)